Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial

被引:222
|
作者
Derman, Richard J.
Kodkany, Bhalchandra S.
Goudar, Shivaprasad S.
Geller, Stacie E.
Naik, Vijaya A.
Bellad, M. B.
Patted, Shobhana S.
Patel, Ashlesha
Edlavitch, Stanley A.
Hartwell, Tyler
Chakraborty, Hrishikesh
Moss, Nancy
机构
[1] Univ Illinois, Coll Med, Dept Obstet & Gynecol MC 808, Chicago, IL 60612 USA
[2] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
[3] Jawaharlal Nehru Med Coll, Belgaum, Karnataka, India
[4] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA
[5] RTI Int, Stat & Epidemiol, Res Triangle Pk, NC USA
[6] NICHHD, Bethesda, MD 20892 USA
来源
LANCET | 2006年 / 368卷 / 9543期
关键词
D O I
10.1016/S0140-6736(06)69522-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Postpartum haemorrhage is a major cause of maternal mortality in the developing world. Although effective methods for prevention and treatment of such haemorrhage exist-such as the uterotonic drug oxytocin - most are not feasible in resource-poor settings where many births occur at home. We aimed to investigate whether oral misoprostol, a potential alternative to oxytocin, could prevent postpartum haemorrhage in a community home-birth setting. Methods In a placebo-controlled trial undertaken between September, 2002, and December, 2005, 1620 women in rural India were randomised to receive oral misoprostol (n=812) or placebo (n=808) after delivery. 25 auxiliary nurse midwives undertook the deliveries, administered the study drug, and measured blood loss. The primary outcome was the incidence of acute postpartum haemorrhage (defined as >= 500 mL bleeding) within 2 h of delivery. Analysis was by intention-to-treat. The trial was registered with the US clinical trials database (http://www.clinicaltrials.gov) as number NCT00097123. Findings Oral misoprostol was associated with a significant reduction in the rate of acute postpartum haemorrhage (12.0% to 6.4%, p < 0.0001; relative risk 0.53 [95% CI 0.39-0.74]) and acute severe postpartum haemorrhage (1.2% to 0.2%, p < 0.0001; 0.20 [0.04-0.91]. One case of postpartum haemorrhage was prevented for every 18 women treated. Misoprostol was also associated with a decrease in mean postpartum blood loss (262.3 mL to 214.3 mL, p < 0.0001). Postpartum haemorrhage rates fell over time in both groups but remained significantly higher in the placebo group. Women taking misoprostol. had a higher rate of transitory symptoms of chills and fever than the control. Interpretation Oral misoprostol was associated with significant decreases in the rate of acute postpartum haemorrhage and mean blood loss. The drug's low cost, ease of administration, stability, and a positive safety profile make it a good option in resource-poor settings.
引用
收藏
页码:1248 / 1253
页数:6
相关论文
共 50 条
  • [41] Thromboelastometry-guided treatment algorithm in postpartum haemorrhage: a randomised, controlled pilot trial
    Jokinen, Samuli
    Kuitunen, Anne
    Uotila, Jukka
    Yli-Hankala, Arvi
    BRITISH JOURNAL OF ANAESTHESIA, 2023, 130 (02) : 165 - 174
  • [42] Schizophrenia medication adherence in a resource-poor setting: randomised controlled trial of supervised treatment in out-patients for schizophrenia (STOPS)
    Farooq, Saeed
    Nazar, Zahid
    Irfan, Muhammad
    Akhter, Javed
    Gul, Ejaz
    Irfan, Uma
    Naeem, Farooq
    BRITISH JOURNAL OF PSYCHIATRY, 2011, 199 (06) : 467 - 472
  • [43] Prophylactic Administration of Per Rectal Misoprostol vs Intramuscular Injection of Oxytocin in Third-stage of Labour for Prevention of Postpartum Haemorrhage: A Randomised Controlled Trial
    Burman, Sougata Kumar
    Samanta, Ritwik
    Lata, Kumari Kanak
    Mukherjee, Jayeeta
    Dey, Tapan Kumar
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (09) : QC09 - QC13
  • [44] Comment on "Joint Statement - Misoprostol for the Treatment of Postpartum Haemorrhage in Low Resource Settings"
    Beckmann, M. W.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2014, 74 (05) : 429 - 429
  • [45] Misoprostol for primary versus secondary prevention of postpartum haemorrhage: a cluster-randomised non-inferiority community trial
    Raghavan, S.
    Geller, S.
    Miller, S.
    Goudar, S. S.
    Anger, H.
    Yadavannavar, M. C.
    Dabash, R.
    Bidri, S. R.
    Gudadinni, M. R.
    Udgiri, R.
    Koch, A. R.
    Bellad, M. B.
    Winikoff, B.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2016, 123 (01) : 120 - 127
  • [46] Oral vs vaginal misoprostol in the induction of labour at term: a randomised controlled trial.
    Shetty, A
    Danielian, P
    Templeton, A
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (06): : 813 - 813
  • [47] Community Dermatology Nursing in Resource-Poor Communities Across Africa
    Kelly, Patricia Ann
    JOURNAL OF THE DERMATOLOGY NURSES ASSOCIATION, 2012, 4 (04) : 244 - 248
  • [48] Preventing Weight Gain in Women in Rural Communities: A Cluster Randomised Controlled Trial
    Lombard, Catherine
    Harrison, Cheryce
    Kozica, Samantha
    Zoungas, Sophia
    Ranasinha, Sanjeeva
    Teede, Helena
    PLOS MEDICINE, 2016, 13 (01)
  • [49] rhuFVIIa in women with a refractory primary postpartum haemorrhage: an international, multicenter, randomised, opened, controlled trial
    Lavigne-Lissalde, G.
    Aya, G.
    Mercier, F.
    Roger-Christophe, S.
    Chauleur, C.
    Morau, E.
    Ducloys, A. -S.
    Mignon, A.
    Raucoule, M.
    Bongain, A.
    Boehlen, F.
    de Moerloose, P.
    Bouvet, S.
    Castelli, C.
    Fabbro-Perray, P.
    Gris, J. -C.
    THROMBOSIS RESEARCH, 2013, 131 : S74 - S74
  • [50] Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: study protocol for a randomised controlled trial
    Nadine Aawar
    Raza Alikhan
    Daniel Bruynseels
    Rebecca Cannings-John
    Rachel Collis
    John Dick
    Christopher Elton
    Roshan Fernando
    Judith Hall
    Kerry Hood
    Nicki Lack
    Shuba Mallaiah
    Helena Maybury
    Jacqueline Nuttall
    Shantini Paranjothy
    Rachel Rayment
    Alexandra Rees
    Julia Sanders
    Julia Townson
    Andrew Weeks
    Peter Collins
    Trials, 16